Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal a…
Biotechnology
US, Charlottesville [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Acumen Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Acumen Pharmaceuticals, Inc. has no acquisition track records yet.